Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor  Eran Elinav, Nitzan Adam,

Slides:



Advertisements
Similar presentations
Volume 132, Issue 1, Pages (January 2007)
Advertisements

Volume 141, Issue 2, Pages e2 (August 2011)
Volume 136, Issue 1, Pages (January 2009)
Cheng-Ming Sun, Edith Deriaud, Claude Leclerc, Richard Lo-Man  Immunity 
Volume 137, Issue 3, Pages (September 2009)
Host-Derived Interleukin-18 Differentially Impacts Regulatory and Conventional T Cell Expansion During Acute Graft-Versus-Host Disease  Robert Zeiser,
Volume 133, Issue 5, Pages (November 2007)
Volume 143, Issue 5, Pages (November 2012)
Teaching Tolerance With a Probiotic Antigen Delivery System
Juyang Kim, Wongyoung Kim, Hyun J. Kim, Sohye Park, Hyun-A
Volume 136, Issue 1, Pages (January 2009)
Volume 136, Issue 4, Pages e3 (April 2009)
Volume 135, Issue 6, Pages (December 2008)
Volume 136, Issue 3, Pages (March 2009)
Volume 130, Issue 2, Pages (February 2006)
Volume 131, Issue 4, Pages (October 2006)
Volume 143, Issue 5, Pages e4 (November 2012)
Volume 133, Issue 1, Pages (July 2007)
Redirection of Regulatory T Cells With Predetermined Specificity for the Treatment of Experimental Colitis in Mice  Eran Elinav, Tova Waks, Zelig Eshhar 
Volume 130, Issue 2, Pages (February 2006)
Volume 134, Issue 1, Pages (January 2008)
Effects and Regulation of Autoreactive CD8+ T Cells in a Transgenic Mouse Model of Autoimmune Hepatitis  Mario Zierden, Elisabeth Kühnen, Margarete Odenthal,
Volume 137, Issue 5, Pages e1 (November 2009)
Volume 142, Issue 2, Pages e2 (February 2012)
Volume 141, Issue 2, Pages e2 (August 2011)
Volume 141, Issue 3, Pages (September 2011)
Volume 132, Issue 7, Pages (June 2007)
Volume 30, Issue 4, Pages (April 2009)
Volume 137, Issue 3, Pages (September 2009)
Volume 18, Issue 5, Pages (May 2003)
Volume 140, Issue 7, Pages (June 2011)
Volume 25, Issue 5, Pages (November 2006)
Volume 141, Issue 5, Pages (November 2011)
Volume 134, Issue 4, Pages e2 (April 2008)
Volume 141, Issue 1, Pages e1 (July 2011)
Volume 143, Issue 3, Pages e2 (September 2012)
Volume 143, Issue 1, Pages (July 2012)
Volume 138, Issue 2, Pages (February 2010)
Volume 132, Issue 1, Pages (January 2007)
Host Basophils Are Dispensable for Induction of Donor T Helper 2 Cell Differentiation and Severity of Experimental Graft-versus-Host Disease  Isao Tawara,
Volume 129, Issue 3, Pages (September 2005)
Therapeutic Action of Ghrelin in a Mouse Model of Colitis
Volume 135, Issue 1, Pages (July 2008)
Volume 135, Issue 5, Pages e5 (November 2008)
Antigen-Presenting Cell Production of IL-10 Inhibits T-Helper 1 and 17 Cell Responses and Suppresses Colitis in Mice  Bo Liu, Susan L. Tonkonogy, R. Balfour.
Volume 135, Issue 2, Pages e2 (August 2008)
Suppression of Murine Colitis and its Associated Cancer by Carcinoembryonic Antigen- Specific Regulatory T Cells  Dan Blat, Ehud Zigmond, Zoya Alteber,
Volume 39, Issue 1, Pages (July 2013)
Volume 142, Issue 5, Pages (May 2012)
Volume 119, Issue 3, Pages (September 2000)
Volume 141, Issue 5, Pages (November 2011)
Volume 36, Issue 6, Pages (June 2012)
Volume 135, Issue 3, Pages (September 2008)
Volume 17, Issue 2, Pages (February 2009)
Volume 36, Issue 4, Pages (April 2012)
Volume 126, Issue 6, Pages (September 2006)
In Vivo Expansion of Regulatory T cells With IL-2/IL-2 mAb Complexes Prevents Anti- factor VIII Immune Responses in Hemophilia A Mice Treated With Factor.
UVA-Induced Immune Suppression Through an Oxidative Pathway
Volume 34, Issue 3, Pages (March 2011)
Volume 30, Issue 4, Pages (April 2009)
Volume 131, Issue 6, Pages (December 2006)
Volume 35, Issue 4, Pages (October 2011)
Volume 32, Issue 1, Pages (January 2010)
Volume 31, Issue 6, Pages (December 2009)
Volume 142, Issue 7, Pages e6 (June 2012)
Engagement of the Type I Interferon Receptor on Dendritic Cells Inhibits T Helper 17 Cell Development: Role of Intracellular Osteopontin  Mari L. Shinohara,
Volume 126, Issue 5, Pages (May 2004)
Volume 13, Issue 11, Pages (December 2015)
A Key Role of Leptin in the Control of Regulatory T Cell Proliferation
Volume 25, Issue 3, Pages (September 2006)
Presentation transcript:

Amelioration of Colitis by Genetically Engineered Murine Regulatory T Cells Redirected by Antigen-Specific Chimeric Receptor  Eran Elinav, Nitzan Adam, Tova Waks, Zelig Eshhar  Gastroenterology  Volume 136, Issue 5, Pages 1721-1731 (May 2009) DOI: 10.1053/j.gastro.2009.01.049 Copyright © 2009 AGA Institute Terms and Conditions

Figure 1 Retroviral transduction of Tregs with a vector encoding anti-TNP TPCR. (A) Assessment of optimal retroviral transduction of isolated CD4+CD25+ Tregs by comparison of the following incubation and preactivation protocols: (I) Complete medium (containing 10% fetal calf serum) and plastic bound anti-CD3/anti-CD28; (II) serum-free medium and anti-CD3/anti-CD28; (III) full medium and Concanavalin A; (IV) serum-free medium and Concanavalin A; (V) full medium and Concanavalin A, repeated retroviral induction after 24 hours; (VI) serum-free medium and Concanavalin A, with repeated retroviral induction after 24 hours. (B) Intracellular Foxp3 expression of the CD4+CD25+ Treg population 48 hours following transduction using the different protocols described above. Results show a representative experiment out of 5 performed. Gastroenterology 2009 136, 1721-1731DOI: (10.1053/j.gastro.2009.01.049) Copyright © 2009 AGA Institute Terms and Conditions

Figure 2 Optimal duration of preactivation of Teff and Treg cells during retroviral transduction. Following isolation, 2 × 106 Teff cells or Tregs were preactivated with 2 mg/mL soluble Concanavalin A for the indicated time periods. Activated cells were then retrovirally transduced with a vector encoding anti-TNP chimeric receptor. Following transduction, cells were incubated for 48 hours and then double stained for intracellular Foxp3 and surface expression of the anti-TNP TPCR. Data shown are from 1 representative experiment out of 3. Gastroenterology 2009 136, 1721-1731DOI: (10.1053/j.gastro.2009.01.049) Copyright © 2009 AGA Institute Terms and Conditions

Figure 3 Enrichment and expansion of the TNP-TPCR-transduced Treg population. Following retroviral transduction with a vector encoding anti-TNP TPCR, Tregs were cultured on plastic-bound 50 μg/mL TNP-BSA. After 6 days of culture, (A) GFP expression and (B) intracellular Foxp3 and anti-TNP-TPCR expression were determined. (C) Appearance and GFP fluorescence of the enriched cell population after 3 and 6 days of culture. Gastroenterology 2009 136, 1721-1731DOI: (10.1053/j.gastro.2009.01.049) Copyright © 2009 AGA Institute Terms and Conditions

Figure 4 TNP-TPCR-transduced Treg antigen-specific suppression of Teff proliferation. (A) TNP-Tg Teff cells (5 × 104) were cocultured with wild-type (WT), TNP-Tg, or TNP-TPCR-transduced Tregs in the presence of 2 × 104 TNP-preloaded irradiated CD11c+ dendritic cells. Teff proliferation was measured after 72 hours by 3H-Thymidine incorporation. Each group was cultured in quadruplicate, and the experiment was repeated 3 times. The data shown represent mean (±SD) of quadruplicate cultures of a single experiment representative of 3. TNP-Tg Teff cell proliferation was significantly lower when cocultured with TNP-Tg and TNP-TPCR transduced Tregs (P < .05). (B) IFN-γ levels from the experiment depicted in A were determined by ELISA. IFN-γ levels were significantly lower in TNP-Tg and TNP-TPCR transduced Treg coculture wells (P < .05). (C) TNP-Tg Teff cells (5 × 104) were cocultured with WT, TNP-Tg, or TNP-TPCR transduced Tregs (1 × 105 in the 2:1 ratio, and progressively reduced doses thereafter) in the presence of 2 × 104 TNP-preloaded irradiated CD11c+ dendritic cells. Teff proliferation was measured after 72 hours by 3H-Thymidine incorporation. Each group was cultured in quadruplicate, and the experiment was repeated 3 times. The data shown represent mean (±SD) of quadruplicate cultures from 1 experiment representative of 3. Gastroenterology 2009 136, 1721-1731DOI: (10.1053/j.gastro.2009.01.049) Copyright © 2009 AGA Institute Terms and Conditions

Figure 5 Adoptive transfer of TNP-TPCR-transduced Tregs ameliorates TNBS colitis. (A–D) TNBS colitis was induced in WT mice (n = 8) on day 0. After 16 hours, Tregs (1 × 105) from wild-type (WT), TNP-Tg, or TNP-TPCR-transduced mice were adoptively transferred to recipient mice. Mice were evaluated for the following parameters: (A) survival rates. (B) Colonoscopic appearance in representative mice. (C) Colonoscopic colitis severity score. (D) Macroscopic appearance of representative colons from each group. TNBS-induced mortality and colitis severity score were significantly lower in TNP-Tg and TNP-TPCR-transduced Treg-administered mice as compared with mice treated with WT-Treg (P < .05). The data shown represent the average from 1 representative experiment. (E) For the assessment of dose response, TNBS colitis was induced in WT mice (n = 9) on day 0. After 16 hours, WT Tregs (0.5 × 105, 1 × 105, 1.5 × 105, 2.5 × 105) or TNP-TPCR-transduced Tregs (0.5 × 105, 1 × 105, 1.5 × 105) were adoptively transferred to recipient mice. TNBS-induced mortality was significantly lower in 1.5 × 105 and 1 × 105 TNP-TPCR-transduced, Treg-administered mice (P < .05). Gastroenterology 2009 136, 1721-1731DOI: (10.1053/j.gastro.2009.01.049) Copyright © 2009 AGA Institute Terms and Conditions

Figure 6 Mechanisms of suppression of TNP TPCR-transduced and TNP-Tg cells. (A) TNP-Tg Teff cells (5 × 104) were cocultured with wild-type (WT), TNP-Tg, or TNP-TPCR-transduced Tregs (5 × 104) in the presence of 2 × 104 TNP-preloaded irradiated CD11c+ dendritic cells. The IL-10 content in the supernatants was measured after 72 hours by ELISA and was significantly lower when Teff cells were cocultured with TNP-Tg and TNP-TPCR-transduced Tregs (P < .05). (B and C) Coculture experiments (as in A) with the addition of 10 μg/mL soluble TGF-β receptor to neutralize TGF-β. TGF-β secretion (ELISA; B) and Teff proliferation (3H-Thymidine incorporation; C) were measured after 72 hours. TNP-Tg Teff cell proliferation, even after elimination of TGF-β, was significantly lower when cocultured with TNP-Tg and TNP-TPCR-transduced Tregs (P < .05). (D) Coculture experiments (as in A) using TNP-TPCR-transduced TGF-β receptor knockout (KO) CD4+ cells as effector cells that were cocultured with either wild-type, TNP-TPCR-transduced, or IL-10-knockout TNP-TPCR-transduced Tregs. Teff proliferation (3H-Thymidine incorporation) was measured after 72 hours and was significantly lower when cocultured with either TNP-TPCR or IL-10-knockout TNP-TPCR-transduced Tregs (P < .05). (E) Coculture experiments (as in A) with and without addition of excess exogenous mouse IL-2 (2000 units/mL). Teff proliferation (3H-Thymidine incorporation) was measured after 72 hours and was significantly lower when cocultured with TNP-Tg and TNP-TPCR-transduced Tregs, with or without IL-2 (P < .05). (F) To study the dependence of Tregs on intercellular contacts, coculture experiments were performed in transwells. Teff cells were incubated in the lower chamber and Tregs in the upper chamber, whereas 2 × 104 irradiated CD11c+ dendritic cells were added to both chambers to enable antigen-specific Teff and Tregs activation. Teff proliferation was measured after 72 hours by 3H-Thymidine incorporation. The data shown represent mean (±SD) of quadruplicate cultures of a representative experiment of 3 performed. Gastroenterology 2009 136, 1721-1731DOI: (10.1053/j.gastro.2009.01.049) Copyright © 2009 AGA Institute Terms and Conditions